Alexandraki KI - Search Results

1

When rare diseases crisscross within the same patient: von Hippel-Lindau and type 1 gastric neuroendocrine tumor.

Alexandraki KI, Spyroglou A, Xekouki P, Bramis KI, Kyriakopoulos G, Barkas K, Papanikolaou IS, Mastorakos G, Konstadoulakis M. Alexandraki KI, et al. Hormones (Athens). 2024 Apr 15. doi: 10.1007/s42000-024-00556-9. Online ahead of print. Hormones (Athens). 2024. PMID: 38619811

2

Medical Therapy for Craniopharyngiomas.

Alexandraki KI, Xekouki P. Alexandraki KI, et al. touchREV Endocrinol. 2021 Nov;17(2):121-132. doi: 10.17925/EE.2021.17.2.121. Epub 2021 Nov 8. touchREV Endocrinol. 2021. PMID: 35118458 Free PMC article. Review.

3

Hobnail Papillary Thyroid Carcinoma, A Systematic Review and Meta-Analysis.

Spyroglou A, Kostopoulos G, Tseleni S, Toulis K, Bramis K, Mastorakos G, Konstadoulakis M, Vamvakidis K, Alexandraki KI. Spyroglou A, et al. Among authors: alexandraki ki. Cancers (Basel). 2022 Jun 3;14(11):2785. doi: 10.3390/cancers14112785. Cancers (Basel). 2022. PMID: 35681765 Free PMC article. Review.

4

Surgical Treatment of Solitary Metachronous Adrenal Metastasis from Urothelial Carcinoma of the Urinary Bladder.

Politis D, Konstantakou P, Bramis K, Alexandraki KI, Spyroglou A, Mastorakos G, Anastasiou I, Papaconstantinou I, Dimopoulos MA. Politis D, et al. Among authors: alexandraki ki. touchREV Endocrinol. 2023 May;19(1):94-97. doi: 10.17925/EE.2023.19.1.94. Epub 2023 Jan 13. touchREV Endocrinol. 2023. PMID: 37313235 Free PMC article.

5

Management of neuroendocrine tumors of unknown primary.

Alexandraki K, Angelousi A, Boutzios G, Kyriakopoulos G, Rontogianni D, Kaltsas G. Alexandraki K, et al. Rev Endocr Metab Disord. 2017 Dec;18(4):423-431. doi: 10.1007/s11154-017-9437-9. Rev Endocr Metab Disord. 2017. PMID: 29199361 Review.

6

Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.

Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI. Kyriakopoulos G, et al. Among authors: alexandraki ki. Ann Transl Med. 2018 Jun;6(12):252. doi: 10.21037/atm.2018.06.27. Ann Transl Med. 2018. PMID: 30069454 Free PMC article. Review.

7

Immunotherapeutics at the spearhead: current status in targeting neuroendocrine neoplasms.

Koumarianou A, Kaltsas GA, Chatzellis E, Kyriakopoulos G, Kolomodi D, Alexandraki KI. Koumarianou A, et al. Among authors: alexandraki ki. Endocrine. 2021 Jul;73(1):232-239. doi: 10.1007/s12020-021-02639-8. Epub 2021 Feb 5. Endocrine. 2021. PMID: 33544352

8

Changing biological behaviour of NETs during the evolution of the disease: progress on progression.

Alexandraki KI, Spyroglou A, Kykalos S, Daskalakis K, Kyriakopoulos G, Sotiropoulos GC, Kaltsas GA, Grossman AB. Alexandraki KI, et al. Endocr Relat Cancer. 2021 Apr 29;28(5):R121-R140. doi: 10.1530/ERC-20-0473. Endocr Relat Cancer. 2021. PMID: 33827047 Review.

9

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.

Alexandraki K, Protogerou AD, Papaioannou TG, Piperi C, Mastorakos G, Lekakis J, Panidis D, Diamanti-Kandarakis E. Alexandraki K, et al. Hormones (Athens). 2006 Apr-Jun;5(2):126-36. doi: 10.14310/horm.2002.11176. Hormones (Athens). 2006. PMID: 16807225 Free article.

10

Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin.

Alexandraki KI, Tsoli M, Kyriakopoulos G, Angelousi A, Nikolopoulos G, Kolomodi D, Kaltsas GA. Alexandraki KI, et al. Minerva Endocrinol. 2019 Dec;44(4):378-386. doi: 10.23736/S0391-1977.19.03012-8. Epub 2019 Apr 15. Minerva Endocrinol. 2019. PMID: 30991795 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page